Last reviewed · How we verify
KT07 Capsule
At a glance
| Generic name | KT07 Capsule |
|---|---|
| Also known as | Lianhua Qingwen Capsule |
| Sponsor | Yiling Pharmaceutical Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Phase I Pharmacokinetics Study for KT07 Capsule (PHASE1)
- A Clinical Trial of KT07 Capsule in the U.S.A (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KT07 Capsule CI brief — competitive landscape report
- KT07 Capsule updates RSS · CI watch RSS
- Yiling Pharmaceutical Inc. portfolio CI